Szejko N - Search Results

1

CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.

Müller-Vahl KR, Pisarenko A, Szejko N, Haas M, Fremer C, Jakubovski E, Musil R, Münchau A, Neuner I, Huys D, van Elst LT, Schröder C, Ringlstetter R, Koch A, Jenz EB, Großhennig A. Müller-Vahl KR, et al. Among authors: szejko n. Psychiatry Res. 2023 May;323:115135. doi: 10.1016/j.psychres.2023.115135. Epub 2023 Feb 28. Psychiatry Res. 2023. PMID: 36878177 Free article. Clinical Trial.

2

[Psychogenic tics: clinical characteristics and prevalence].

Janik P, Milanowski L, Szejko N. Janik P, et al. Among authors: szejko n. Psychiatr Pol. 2014 Jul-Aug;48(4):835-45. Psychiatr Pol. 2014. PMID: 25314807 Polish.

3

Tarkovsky's Stalker: existentialism and mental health.

Artukoglu BB, Szejko N. Artukoglu BB, et al. Among authors: szejko n. Lancet Psychiatry. 2020 Jan;7(1):24-26. doi: 10.1016/S2215-0366(19)30474-2. Epub 2019 Dec 10. Lancet Psychiatry. 2020. PMID: 32353341 No abstract available.

4

Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Andersen PM, Kuzma-Kozakiewicz M, Keller J, Aho-Oezhan HEA, Ciecwierska K, Szejko N, Vázquez C, Böhm S, Badura-Lotter G, Meyer T, Petri S, Linse K, Hermann A, Semb O, Stenberg E, Nackberg S, Dorst J, Uttner I, Häggström AC, Ludolph AC, Lulé D. Andersen PM, et al. Among authors: szejko n. J Neurol. 2018 Jul;265(7):1600-1606. doi: 10.1007/s00415-018-8861-4. Epub 2018 May 4. J Neurol. 2018. PMID: 29728768

5

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.

Müller-Vahl KR, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, Berding G. Müller-Vahl KR, et al. Among authors: szejko n. Sci Rep. 2019 Jan 30;9(1):972. doi: 10.1038/s41598-018-37710-4. Sci Rep. 2019. PMID: 30700759 Free PMC article.

6

Prevalence and Clinical Correlates of Self-Harm Behaviors in Gilles de la Tourette Syndrome.

Szejko N, Jakubczyk A, Janik P. Szejko N, et al. Front Psychiatry. 2019 Sep 5;10:638. doi: 10.3389/fpsyt.2019.00638. eCollection 2019. Front Psychiatry. 2019. PMID: 31543843 Free PMC article.

7

Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey.

Milosev LM, Psathakis N, Szejko N, Jakubovski E, Müller-Vahl KR. Milosev LM, et al. Among authors: szejko n. Cannabis Cannabinoid Res. 2019 Dec 9;4(4):265-274. doi: 10.1089/can.2018.0050. eCollection 2019. Cannabis Cannabinoid Res. 2019. PMID: 31872061 Free PMC article.

8

Intravenous Immunoglobulin Treatment Did Not Improve Tics in a Patient With Gilles de la Tourette Syndrome and Intrathecal Antibody Synthesis.

Szejko N, Fremer C, Sühs KW, Macul Ferreira de Barros P, Müller-Vahl KR. Szejko N, et al. Front Neurol. 2020 Feb 28;11:110. doi: 10.3389/fneur.2020.00110. eCollection 2020. Front Neurol. 2020. PMID: 32180755 Free PMC article.

9

Author Correction: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.

Müller-Vahl KR, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, Berding G. Müller-Vahl KR, et al. Among authors: szejko n. Sci Rep. 2020 Jul 1;10(1):11092. doi: 10.1038/s41598-020-68278-7. Sci Rep. 2020. PMID: 32606446 Free PMC article.

10

Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature.

Szejko N, Fremer C, Müller-Vahl KR. Szejko N, et al. Front Psychiatry. 2020 Jul 21;11:681. doi: 10.3389/fpsyt.2020.00681. eCollection 2020. Front Psychiatry. 2020. PMID: 32848902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page